EP02.01. Synergism of KRAS G12C Inhibitor and mTOR Inhibitor in Lung Adenocarcinoma and Squamous Cell Carcinoma - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Masaoki Ito
Meta Tag
Speaker Masaoki Ito
Topic Tumor Biology: Preclinical Biology - Molecular Therapeutic Targets
therapeutic potential
KRAS G12C inhibitor
mTOR inhibitor
lung adenocarcinoma
squamous cell carcinoma
KRAS G12C mutation
combination effect
KRAS inhibitors
targetable somatic variant
Powered By